Korean J Gastroenterol.  2011 Jun;57(6):333-334. 10.4166/kjg.2011.57.6.333.

Prediction of Post-operative Mortality in Patients with Cirrhosis: Growth of Child to MELD

• Lim YS

• KMID: 1792795
• DOI: http://doi.org/10.4166/kjg.2011.57.6.333

Abstract

No abstract available.

Reference

References

1. Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010; 121:192–204.

2. Blei AT, Mazhar S, Davidson CJ, Flamm SL, Abecassis M, Gheorghiade M. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome. J Clin Gastroenterol. 2007; 41(Suppl 3):S323–S329.

3. Arroyo V, Jiménez W. Complications of cirrhosis. II. Renal and cir-culatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol. 2000; 32(1 Suppl):157–170.

4. Douard R, Lentschener C, Ozier Y, Dousset B. Operative risks of digestive surgery in cirrhotic patients. Gastroenterol Clin Biol. 2009; 33:555–564.

5. Friedman LS. The risk of surgery in patients with liver disease. Hepatology. 1999; 29:1617–1623.

6. Patel T. Surgery in the patient with liver disease. Mayo Clin Proc. 1999; 74:593–599.

7. Northup PG, Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005; 242:244–251.

8. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007; 132:1261–1269.

9. Song C, Yoon M, Kim H, et al. Usefulness of model for end-stage liver disease (MELD) score for predicting mortality after intra-abdominal surgery in patients with liver cirrhosis in a single hospital. Korean J Gastroenterol. 2011; 57:340–345.

10. Kamath PS, Kim WR. Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007; 45:797–805.